Hepatopulmonary Shunt Ratio Verification Model for Transarterial Radioembolization
- 1 September 2024
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Radiopharmaceuticals
- Vol. 17 (3) , 276-284
Abstract
Introduction: The most important toxicity of transarterial radioembolization therapy applied in liver malignancies is radiation pneumonitis and fibrosis due to hepatopulmonary shunt of Yttrium-90 (90Y) microspheres. Currently, Technetium-99m macroaggregated albumin (99mTc-MAA) scintigraphic images are used to estimate lung shunt fraction (LSF) before treatment. The aim of this study was to create a phantom to calculate exact LFS rates according to 99mTc activities in the phantom and to compare these rates with LSF values calculated from scintigraphic images. Materials and Methods: A 3D-printed lung and liver phantom containing two liver tumors was developed from Polylactic Acid (PLA) material, which is similar to the normal-sized human body in terms of texture and density. Actual %LSFs were calculated by filling phantoms and tumors with 99mTc radionuclide. After the phantoms were placed in the water tank made of plexiglass material, planar, SPECT, and SPECT/CT images were obtained. The actual LSF ratio calculated from the activity amounts filled into the phantom was used for the verification of the quantification of scintigraphic images and the results obtained by the Simplicity90YTM method. Results: In our experimental model, LSFs calculated from 99mTc activities filled into the lungs, normal liver, small tumor, and large tumor were found to be 0%, 6.2%, 10.8%, and 16.9%. According to these actual LSF values, LSF values were calculated from planar, SPECT/CT (without attenuation correction), and SPECT/CT (with both attenuation and scatter correction) scintigraphic images of the phantom. In each scintigraphy, doses were calculated for lung, small tumor, large tumor, normal liver, and Simplicity90YTM. The doses calculated from planar and SPECT/CT (NoAC+NoSC) images were found to be higher than the actual doses. The doses calculated from SPECT/CT (with AC+with SC) images and Simplicity90YTM were found to be closer to the real dose values. Conclusion: LSF is critical in dosimetry calculations of 90Y microsphere therapy. The newly introduced hepatopulmonary shunt phantom in this study is suitable for LSF verification for all models/brands of SPECT and SPECT/CT devices.Keywords
Funding Information
- Scientific and Technological Research Council of Turkey (123S150)
This publication has 20 references indexed in Scilit:
- EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compoundsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- Tumor-to-Normal Ratio Relationship between Planning Technetium-99 Macroaggregated Albumin and Posttherapy Yttrium-90 Bremsstrahlung SPECT/CTJournal of Vascular and Interventional Radiology, 2021
- International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheresEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- A guide to 90Y radioembolization and its dosimetryPhysica Medica, 2019
- Calculation of lung mean dose and quantification of error for 90Y‐microsphere radioembolization using 99mTc‐MAA SPECT/CT and diagnostic chest CTMedical Physics, 2019
- Radioembolization lung shunt estimation based on a 90Y pretreatment procedure: A phantom studyMedical Physics, 2018
- The Utility of Unilobar Technetium-99m Macroaggregated Albumin to Predict Pulmonary Toxicity In Bilobar Hepatocellular Carcinoma prior to Yttrium-90 RadioembolizationJournal of Vascular and Interventional Radiology, 2016
- Semi-Quantitative Analysis of Post-Transarterial Radioembolization 90Y Microsphere Positron Emission Tomography Combined with Computed Tomography (PET/CT) Images in Advanced Liver Malignancy: Comparison With 99mTc Macroaggregated Albumin (MAA) Single Photon Emission Computed Tomography (SPECT)Nuclear Medicine and Molecular Imaging, 2015
- Clinical impact of 99mTc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with 90Y-loaded microspheresEuropean Journal of Nuclear Medicine and Molecular Imaging, 2015
- Lung Dose Calculation With SPECT/CT for 90Yittrium Radioembolization of Liver CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013